Works by Dulovic, Alex
Results: 21
Characteristics Associated with COVID-19 Breakthrough Infections after Booster Vaccinations in Healthcare Workers: Insights from the TüSeRe:exact Study.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 6, p. 1571, doi. 10.3390/jcm13061571
- By:
- Publication type:
- Article
Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination.
- Published in:
- Emerging Infectious Diseases, 2022, v. 28, n. 4, p. 743, doi. 10.3201/eid2804.211907
- By:
- Publication type:
- Article
SARS-CoV-2 specific sIgA in saliva increases after disease-related video stimulation.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-47798-y
- By:
- Publication type:
- Article
Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1004045
- By:
- Publication type:
- Article
Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in Germany.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.828053
- By:
- Publication type:
- Article
Robust and durable serological response following pediatric SARS-CoV-2 infection.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-021-27595-9
- By:
- Publication type:
- Article
Borrelia multiplex: a bead-based multiplex assay for the simultaneous detection of Borrelia specific IgG/IgM class antibodies.
- Published in:
- 2022
- By:
- Publication type:
- journal article
In-depth analysis of serum antibodies against Epstein-Barr virus lifecycle proteins, and EBNA1, ANO2, GlialCAM and CRYAB peptides in patients with multiple sclerosis.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1487523
- By:
- Publication type:
- Article
COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-10987-2
- By:
- Publication type:
- Article
Association of known SARS-CoV-2 serostatus and adherence to personal protection measures and the impact of personal protective measures on seropositivity in a population-based cross-sectional study (MuSPAD) in Germany.
- Published in:
- BMC Public Health, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12889-023-17121-5
- By:
- Publication type:
- Article
RNAi-mediated knockdown of daf-12 in the model parasitic nematode Strongyloides ratti.
- Published in:
- PLoS Pathogens, 2019, v. 15, n. 3, p. 1, doi. 10.1371/journal.ppat.1007705
- By:
- Publication type:
- Article
Development and validation of a respiratory syncytial virus multiplex immunoassay.
- Published in:
- Infection, 2024, v. 52, n. 2, p. 597, doi. 10.1007/s15010-024-02180-6
- By:
- Publication type:
- Article
NeutrobodyPlex—monitoring SARS‐CoV‐2 neutralizing immune responses using nanobodies.
- Published in:
- EMBO Reports, 2021, v. 22, n. 5, p. 1, doi. 10.15252/embr.202052325
- By:
- Publication type:
- Article
Chemotactic and temperature-dependent responses of the Strongyloidoidea superfamily of nematodes.
- Published in:
- Parasitology, 2022, v. 149, n. 1, p. 116, doi. 10.1017/S003118202100161X
- By:
- Publication type:
- Article
STAR SIGN study: Evaluation of COVID‐19 vaccine efficacy against the SARS‐CoV‐2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 7, p. 678, doi. 10.1111/apt.17661
- By:
- Publication type:
- Article
Rhabditophanes diutinus a parthenogenetic clade IV nematode with dauer larvae.
- Published in:
- PLoS Pathogens, 2020, v. 16, n. 12, p. 1, doi. 10.1371/journal.ppat.1009113
- By:
- Publication type:
- Article
Correction: RNAi-mediated knockdown of daf-12 in the model parasitic nematode Strongyloides ratti.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease.
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 774, doi. 10.3390/vaccines12070774
- By:
- Publication type:
- Article
XBB.1.5‐Adapted COVID‐19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS‐CoV‐2 JN.1 Variant in Patients With Inflammatory Bowel Disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 299, doi. 10.1111/apt.18349
- By:
- Publication type:
- Article
Immune response to SARS-CoV-2 variants of concern in vaccinated individuals.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-23473-6
- By:
- Publication type:
- Article
Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-20973-3
- By:
- Publication type:
- Article